Teva Pharmaceuticals CEO Richard Francis Condemns Attacks on Israeli Civilians

09 October 2023 | Monday | News

In a heartfelt statement released today, Richard Francis, the President and Chief Executive Officer of Teva Pharmaceuticals, expressed his deep sadness and shock in response to the recent brutal attacks on Israeli civilians. Mr. Francis issued his statement in the wake of an unprecedented assault that has taken place in Israel over the past few days.
Richard Francis, President and Chief Executive Officer, Teva Pharmaceuticals

Richard Francis, President and Chief Executive Officer, Teva Pharmaceuticals

Since the early hours of Saturday, Israel has witnessed a massive and horrifying assault on innocent lives, leaving hundreds dead, hundreds more injured, and a significant number of civilians held captive, including women, children, toddlers, and elderly individuals. Mr. Francis conveyed his profound sympathy for the victims and their families, emphasizing that they are in his thoughts and heart during this challenging time.

As the leader of Teva Pharmaceuticals, Richard Francis stressed the company's fundamental responsibility and commitment to support and care for its employees, both in Israel and around the world. He highlighted the measures the company is taking to closely monitor the situation, with a primary focus on ensuring the wellbeing of their employees and maintaining business continuity to deliver essential medicines to patients.

Mr. Francis acknowledged the devastating nature of the situation but commended the unwavering resilience and dedication of Teva Pharmaceuticals' colleagues in Israel. He urged them to take care of themselves and their loved ones while expressing his pride in their ability to rise above the challenges presented by these troubling times.

The statement concluded with a message of solidarity and hope, as Teva Pharmaceuticals and its CEO pledged to navigate through these extremely difficult times together.

The official hashtag #tevapharm and #standwithisrael has been used to show support and unity during this crisis. The pharmaceutical company and its CEO join the global community in condemning violence against civilians and advocating for peace and stability in the region.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in